These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 6704958
21. TALL-104 cell therapy of human solid tumors implanted in immunodeficient (SCID) mice. Cesano A, Visonneau S, Santoli D. Anticancer Res; 1998; 18(4A):2289-95. PubMed ID: 9703868 [Abstract] [Full Text] [Related]
22. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Pearlstein E, Ambrogio C, Karpatkin S. Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304 [Abstract] [Full Text] [Related]
28. Characterization and responsiveness of the Madison 109 lung carcinoma to various antitumor agents. Marks TA, Woodman RJ, Geran RI, Billups LH, Madison RM. Cancer Treat Rep; 1977 Nov; 61(8):1459-70. PubMed ID: 922751 [Abstract] [Full Text] [Related]
31. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors. Loveless SE, Munson AE. Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000 [Abstract] [Full Text] [Related]
32. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt. Sava G, Zorzet S, Perissin L, Lassiani L, Tomasic J. Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598 [Abstract] [Full Text] [Related]
33. Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors. Abe S, Yoshioka O, Masuko Y, Tsubouchi J, Kohno M, Nakajima H, Yamazaki M, Mizono D. Gan; 1982 Feb; 73(1):91-6. PubMed ID: 6749591 [Abstract] [Full Text] [Related]
34. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci. Kanwar JR, Kanwar RK, Pandey S, Ching LM, Krissansen GW. Cancer Res; 2001 Mar 01; 61(5):1948-56. PubMed ID: 11280751 [Abstract] [Full Text] [Related]
35. Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. Cabanes A, Even-Chen S, Zimberoff J, Barenholz Y, Kedar E, Gabizon A. Clin Cancer Res; 1999 Mar 01; 5(3):687-93. PubMed ID: 10100723 [Abstract] [Full Text] [Related]
36. Anticancer activity of an aqueous mistletoe extract (AME) in syngeneic murine tumor models. Burger AM, Mengs U, Schüler JB, Fiebig HH. Anticancer Res; 2001 Mar 01; 21(3B):1965-8. PubMed ID: 11497284 [Abstract] [Full Text] [Related]
38. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation. Kim JA, Averbook BJ, Chambers K, Rothchild K, Kjaergaard J, Papay R, Shu S. Cancer Res; 2001 Mar 01; 61(5):2031-7. PubMed ID: 11280763 [Abstract] [Full Text] [Related]